pdufa.bio
HomeReadouts › November 2026

November 2026 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for November 2026, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← October 2026December 2026 →
18 readouts
ATOS · Nov 2026 (est.)
Z-Endoxifen: Breast Neoplasms
Awaiting data
APGE · Nov 2026 (est.)
APG777: Atopic Dermatitis
Awaiting data
TLX · Nov 2026 (est.)
177Lu-TLX591: Prostate Adenocarcinoma
ERAS · Nov 2026 (est.)
Naporafenib: Advanced or Metastatic Solid Tumors
Awaiting data
GILD · Nov 2026 (est.)
Sacituzumab Govitecan: Esophageal Squamous Cell Carcinoma
IMUX · Nov 2026 (est.)
IMU-838 tablets: Multiple Sclerosis
Awaiting dataupdated 4mo ago
IOVA · Nov 2026 (est.)
Lifileucel plus Pembrolizumab: Metastatic Melanoma
Awaiting dataupdated 10mo ago
ONC · Nov 2026 (est.)
BGB-11417: Relapsed/Refractory Multiple Myeloma
TYRA · Nov 2026 (est.)
TYRA-300: Locally Advanced Urothelial Carcinoma
Awaiting dataupdated 5mo ago
VIR · Nov 2026 (est.)
Bulevirtide: Viral Hepatitis
Awaiting dataupdated 5mo ago
VXRT · Nov 2026 (est.)
VXA-COV2-3.3: SARS-CoV2
Awaiting data
ZURA · Nov 2026 (est.)
Tibulizumab: Hidradenitis Suppurativa (HS)
Awaiting data
ELTX · Nov 2026 (est.)
ELI-002 7P: Pancreatic Ductal Adenocarcinoma
Awaiting data
CRDF · Nov 2026 (est.)
Onvansertib: Metastatic Colorectal Cancer
Awaiting data
BYSI · Nov 2026 (est.)
Docetaxel + Plinabulin: Multiple Myeloma
Awaiting dataupdated 6mo ago
CGEM · Nov 2026 (est.)
CLN-081: NHL
Awaiting dataupdated 26mo ago
PHAR · Nov 2026 (est.)
Leniolisib: APDS
SNY · Nov 2026 (est.)
Rilzabrutinib: Immune Thrombocytopenia
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).